Universe · entity
Samsara BioCapital, LLC
Institutional manager (13F) · CIK 1744967
13F holdings · as of 2026-03-31 · top 22 · reported portfolio $1.0B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | <![CDATA[SCHOLAR ROCK HLDG CORP]]> | $339M | 6,897,652 |
| 2 | <![CDATA[MINERALYS THERAPEUTICS INC]]> | $159M | 5,871,018 |
| 3 | <![CDATA[ALUMIS INC]]> | $140M | 6,345,219 |
| 4 | <![CDATA[SEPTERNA INC]]> | $76M | 3,149,128 |
| 5 | <![CDATA[KALARIS THERAPEUTICS INC]]> | $75M | 12,948,081 |
| 6 | <![CDATA[SPYGLASS PHARMA INC]]> | $55M | 2,109,953 |
| 7 | <![CDATA[NEUROGENE INC]]> | $35M | 1,717,127 |
| 8 | <![CDATA[INVENTIVA SA]]> | $29M | 5,194,805 |
| 9 | <![CDATA[SUTRO BIOPHARMA INC]]> | $26M | 1,062,872 |
| 10 | <![CDATA[JADE BIOSCIENCES INC]]> | $14M | 968,798 |
| 11 | <![CDATA[VTV THERAPEUTICS INC]]> | $12M | 298,496 |
| 12 | <![CDATA[AQUESTIVE THERAPEUTICS INC]]> | $10M | 2,500,000 |
| 13 | <![CDATA[X4 PHARMACEUTICALS INC]]> | $8M | 1,832,566 |
| 14 | <![CDATA[NKARTA INC]]> | $7M | 3,507,666 |
| 15 | <![CDATA[ARCELLX INC]]> | $7M | 60,873 |
| 16 | <![CDATA[UPSTREAM BIO INC]]> | $7M | 736,047 |
| 17 | <![CDATA[ABIVAX SA]]> | $6M | 56,581 |
| 18 | <![CDATA[AGOMAB THERAPEUTICS NV]]> | $6M | 600,000 |
| 19 | <![CDATA[RANI THERAPEUTICS HLDGS INC]]> | $6M | 8,500,000 |
| 20 | <![CDATA[COHERUS ONCOLOGY INC]]> | $6M | 3,428,571 |
| 21 | <![CDATA[PALVELLA THERAPEUTICS INC NE]]> | $5M | 38,432 |
| 22 | <![CDATA[GOSSAMER BIO INC]]> | $2M | 7,222,559 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.